Establishment Labs' (ESTA) Sell (D-) Rating Reaffirmed at Weiss Ratings

Key Points

• Establishment Labs had its stock rating reaffirmed as "sell (D-)" by Weiss Ratings, amidst mixed ratings from other analysts including a "buy" from Needham & Company with a $48 target price.
• The company reported a quarterly loss of ($0.57) per share, slightly missing analyst expectations, but revenue increased by 16.1% year-over-year to $51.30 million.
• Hedge funds significantly increased their positions in Establishment Labs, with institutional investors now owning 72.91% of the stock.

Establishment Labs (NASDAQ:ESTA - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

Other research analysts have also recently issued reports about the stock. Citigroup reissued a "neutral" rating on shares of Establishment Labs in a research report on Tuesday. Needham & Company LLC reissued a "buy" rating and set a $48.00 price target on shares of Establishment Labs in a research report on Friday, June 13th. Wall Street Zen raised shares of Establishment Labs from a "sell" rating to a "hold" rating in a research report on Saturday, September 20th. Canaccord Genuity Group assumed coverage on shares of Establishment Labs in a report on Wednesday, August 20th. They issued a "buy" rating and a $60.00 target price for the company. Finally, Mizuho lifted their target price on shares of Establishment Labs from $58.00 to $70.00 and gave the stock an "outperform" rating in a report on Wednesday, July 16th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Establishment Labs currently has a consensus rating of "Moderate Buy" and a consensus target price of $56.50.

Establishment Labs Trading Down 0.8%

Shares of NASDAQ ESTA opened at $40.12 on Wednesday. Establishment Labs has a 1 year low of $26.56 and a 1 year high of $50.85. The stock has a market cap of $1.16 billion, a P/E ratio of -13.15 and a beta of 0.85. The firm has a 50-day moving average of $39.69 and a 200 day moving average of $38.06. The company has a debt-to-equity ratio of 9.71, a current ratio of 2.84 and a quick ratio of 1.67.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.54) by ($0.03). Establishment Labs had a negative net margin of 49.89% and a negative return on equity of 224.34%. The business had revenue of $51.30 million for the quarter, compared to analysts' expectations of $50.80 million. During the same period last year, the business earned ($0.62) earnings per share. The company's revenue was up 16.1% on a year-over-year basis. Establishment Labs has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Establishment Labs will post -2.41 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. ANTIPODES PARTNERS Ltd purchased a new position in shares of Establishment Labs during the first quarter valued at approximately $81,000. Osaic Holdings Inc. raised its holdings in shares of Establishment Labs by 900.0% during the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company's stock valued at $85,000 after purchasing an additional 1,800 shares during the last quarter. CWM LLC raised its holdings in shares of Establishment Labs by 45.9% during the second quarter. CWM LLC now owns 2,182 shares of the company's stock valued at $93,000 after purchasing an additional 686 shares during the last quarter. Elevation Point Wealth Partners LLC purchased a new position in shares of Establishment Labs during the first quarter valued at approximately $207,000. Finally, Patriot Financial Group Insurance Agency LLC grew its position in Establishment Labs by 5.2% during the second quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company's stock valued at $257,000 after buying an additional 300 shares during the period. 72.91% of the stock is owned by hedge funds and other institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.